Switchable CAR-T Cells Outperformed Traditional Antibody-Redirected Therapeutics Targeting Breast Cancers-Reference-Cited by-同舟云学术

Switchable CAR-T Cells Outperformed Traditional Antibody-Redirected Therapeutics Targeting Breast Cancers

Published:2021-04-15 Issue:5 Volume:10 Page:1176-1183
ISSN:2161-5063
Container-title:ACS Synthetic Biology
language:en
Short-container-title:ACS Synth. Biol.

Author:

Cao Yu J.¹^ORCID,Wang Xuechun¹,Wang Zhidong¹,Zhao Lijun¹,Li Shuhong¹,Zhang Zhuxia¹,Wei Xiaoyi¹,Yun Hwayoung²^ORCID,Choi Sei-hyun³,Liu Zhong⁴,Zhao Lili⁵,Kazane Stephanie A.⁶

Affiliation:

1. State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, Guangdong 518055, China

2. College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea

3. Department of Chemistry, The Scripps Research Institute, La Jolla, California 92037, United States

4. Shandong New Time Pharmaceutical Co., Ltd, No. 1 North Outer Ring Road, Feixian County, Shandong 273400, China

5. State Engineering Laboratory of High Expression of Mammalian Cells, No. 1 North Outer Ring Road, Feixian County, Shandong 273400, China

6. California Institute for Biomedical Research, 11119 North Torrey Pines Road, La Jolla, California 92037, United States

Funder

National Natural Science Foundation of China

Guangdong Natural Science Foundation

Shenzhen Science and Technology Innovation Program

National Key R&D Program of China

The Key Research and Development of Program of Shandong Province

Publisher

American Chemical Society (ACS)

Subject

Biochemistry, Genetics and Molecular Biology (miscellaneous),Biomedical Engineering,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acssynbio.1c00007

Reference29 articles.

1. The expanding role of immunotherapy

2. Antibody therapy of cancer

3. Building better monoclonal antibody-based therapeutics

4. Multiformat T-Cell-Engaging Bispecific Antibodies Targeting Human Breast Cancers

5. Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Targeted Cancer Therapy: Are PDCs the Next Generation of ADCs?;Journal of Medicinal Chemistry;2024-07-09

2. Chimeric antigen receptor‐based immunotherapy in breast cancer: Recent progress in China;Cancer;2023-11-11

3. Applications of genetic code expansion technology in eukaryotes;Protein & Cell;2023-10-17

4. Cellular Therapy for Lung Cancer: Focusing on Chimeric Antigen Receptor T (CAR T) Cells and Tumor-Infiltrating Lymphocyte (TIL) Therapy;Cancers;2023-07-23

5. Universal redirection of CAR T cells against solid tumours via membrane-inserted ligands for the CAR;Nature Biomedical Engineering;2023-06-08